Concepedia

Jolique A. van Ipenburg

JA

8

Publications

268

Citations

8

H-Index

2017

Active since

Affiliations

Erasmus MC(Current)

Rotterdam Eye Hospital

Radboud University Nijmegen

Radboud University Medical Center

Leiden University Medical Center

Jolique A. van Ipenburg is an author at Erasmus MC specializing in oncology, pathology, and cancer research.

ORCID

Top concepts

Publications per year

2017–2024

8

Publications

8

Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma

Eva C Coopmans, Sebastiaan W F van Meyel, Kay Pieterman et al. · European Journal of Endocrinology · 2019 · 56 citations · Full text

, , +11

Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma

Marc Lucas Ooft, Jolique A. van Ipenburg, Weibel W. Braunius et al. · Oral Oncology · 2017 · 55 citations

, , +8

Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma

Marc Lucas Ooft, Jolique A. van Ipenburg, Maxime E. Sanders et al. · Journal of Clinical Pathology · 2017 · 50 citations

Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis

Natasha M. van Poppelen, Jolique A. van Ipenburg, Quincy van den Bosch et al. · International Journal of Molecular Sciences · 2021 · 33 citations · Full text

Prognostic value of <i>TERT</i> promoter mutations in conjunctival melanomas in addition to clinicopathological features

Jolique A. van Ipenburg, Nicole C. Naus, Hendrikus J. Dubbink et al. · British Journal of Ophthalmology · 2020 · 24 citations

Rows per page

1–5 of 8